Clinical Trial Update: Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With Ketoconazole

View source ↗

Summary

The trial investigating biomarkers in bone marrow and blood from prostate cancer patients treated with ketoconazole has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Ketoconazole (Ketoconazole)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Prostate Cancer | Status: WITHDRAWN